[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Grand Mal Seizure Market Growth (Status and Outlook) 2024-2030

May 2024 | 95 pages | ID: G07284B11417EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.

The global Grand Mal Seizure market size is projected to grow from US$ 19360 million in 2023 to US$ 22990 million in 2030; it is expected to grow at a CAGR of 2.5% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Grand Mal Seizure Industry Forecast” looks at past sales and reviews total world Grand Mal Seizure sales in 2023, providing a comprehensive analysis by region and market sector of projected Grand Mal Seizure sales for 2024 through 2030. With Grand Mal Seizure sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Grand Mal Seizure industry.

This Insight Report provides a comprehensive analysis of the global Grand Mal Seizure landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Grand Mal Seizure portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Grand Mal Seizure market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Grand Mal Seizure and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Grand Mal Seizure.

The Americas accounts for the significant market share owing to extensive use of medications and greater expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global grand mal seizures market. The concentration of the major medical diagnostic device manufacturers in the developed regions is also adding fuel to the market. Europe is the second largest market due to a high disposable income and rising awareness about the grand mal seizures.

This report presents a comprehensive overview, market shares, and growth opportunities of Grand Mal Seizure market by product type, application, key players and key regions and countries.

Segmentation by type
  • Barbiturates
  • Hydantoin
  • Phenyltriazine
  • Iminostilbenes
  • Benzodiazepines
  • Aliphatic Carboxylic Acid
  • Others
Segmentation by application
  • Hospitals
  • Clinics
  • Academic and Research Centers
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pfizer
  • Johnson & Johnson
  • UCB Celltech
  • Abbott Laboratories
  • GlaxoSmithKline
  • Novartis
  • Sanofi
  • Takeda
  • Teva Pharmaceutical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Grand Mal Seizure Market Size 2019-2030
  2.1.2 Grand Mal Seizure Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Grand Mal Seizure Segment by Type
  2.2.1 Barbiturates
  2.2.2 Hydantoin
  2.2.3 Phenyltriazine
  2.2.4 Iminostilbenes
  2.2.5 Benzodiazepines
  2.2.6 Aliphatic Carboxylic Acid
  2.2.7 Others
2.3 Grand Mal Seizure Market Size by Type
  2.3.1 Grand Mal Seizure Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Grand Mal Seizure Market Size Market Share by Type (2019-2024)
2.4 Grand Mal Seizure Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Academic and Research Centers
  2.4.4 Others
2.5 Grand Mal Seizure Market Size by Application
  2.5.1 Grand Mal Seizure Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Grand Mal Seizure Market Size Market Share by Application (2019-2024)

3 GRAND MAL SEIZURE MARKET SIZE BY PLAYER

3.1 Grand Mal Seizure Market Size Market Share by Players
  3.1.1 Global Grand Mal Seizure Revenue by Players (2019-2024)
  3.1.2 Global Grand Mal Seizure Revenue Market Share by Players (2019-2024)
3.2 Global Grand Mal Seizure Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GRAND MAL SEIZURE BY REGIONS

4.1 Grand Mal Seizure Market Size by Regions (2019-2024)
4.2 Americas Grand Mal Seizure Market Size Growth (2019-2024)
4.3 APAC Grand Mal Seizure Market Size Growth (2019-2024)
4.4 Europe Grand Mal Seizure Market Size Growth (2019-2024)
4.5 Middle East & Africa Grand Mal Seizure Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Grand Mal Seizure Market Size by Country (2019-2024)
5.2 Americas Grand Mal Seizure Market Size by Type (2019-2024)
5.3 Americas Grand Mal Seizure Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Grand Mal Seizure Market Size by Region (2019-2024)
6.2 APAC Grand Mal Seizure Market Size by Type (2019-2024)
6.3 APAC Grand Mal Seizure Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Grand Mal Seizure by Country (2019-2024)
7.2 Europe Grand Mal Seizure Market Size by Type (2019-2024)
7.3 Europe Grand Mal Seizure Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Grand Mal Seizure by Region (2019-2024)
8.2 Middle East & Africa Grand Mal Seizure Market Size by Type (2019-2024)
8.3 Middle East & Africa Grand Mal Seizure Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GRAND MAL SEIZURE MARKET FORECAST

10.1 Global Grand Mal Seizure Forecast by Regions (2025-2030)
  10.1.1 Global Grand Mal Seizure Forecast by Regions (2025-2030)
  10.1.2 Americas Grand Mal Seizure Forecast
  10.1.3 APAC Grand Mal Seizure Forecast
  10.1.4 Europe Grand Mal Seizure Forecast
  10.1.5 Middle East & Africa Grand Mal Seizure Forecast
10.2 Americas Grand Mal Seizure Forecast by Country (2025-2030)
  10.2.1 United States Grand Mal Seizure Market Forecast
  10.2.2 Canada Grand Mal Seizure Market Forecast
  10.2.3 Mexico Grand Mal Seizure Market Forecast
  10.2.4 Brazil Grand Mal Seizure Market Forecast
10.3 APAC Grand Mal Seizure Forecast by Region (2025-2030)
  10.3.1 China Grand Mal Seizure Market Forecast
  10.3.2 Japan Grand Mal Seizure Market Forecast
  10.3.3 Korea Grand Mal Seizure Market Forecast
  10.3.4 Southeast Asia Grand Mal Seizure Market Forecast
  10.3.5 India Grand Mal Seizure Market Forecast
  10.3.6 Australia Grand Mal Seizure Market Forecast
10.4 Europe Grand Mal Seizure Forecast by Country (2025-2030)
  10.4.1 Germany Grand Mal Seizure Market Forecast
  10.4.2 France Grand Mal Seizure Market Forecast
  10.4.3 UK Grand Mal Seizure Market Forecast
  10.4.4 Italy Grand Mal Seizure Market Forecast
  10.4.5 Russia Grand Mal Seizure Market Forecast
10.5 Middle East & Africa Grand Mal Seizure Forecast by Region (2025-2030)
  10.5.1 Egypt Grand Mal Seizure Market Forecast
  10.5.2 South Africa Grand Mal Seizure Market Forecast
  10.5.3 Israel Grand Mal Seizure Market Forecast
  10.5.4 Turkey Grand Mal Seizure Market Forecast
  10.5.5 GCC Countries Grand Mal Seizure Market Forecast
10.6 Global Grand Mal Seizure Forecast by Type (2025-2030)
10.7 Global Grand Mal Seizure Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Grand Mal Seizure Product Offered
  11.1.3 Pfizer Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Information
  11.2.2 Johnson & Johnson Grand Mal Seizure Product Offered
  11.2.3 Johnson & Johnson Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson Latest Developments
11.3 UCB Celltech
  11.3.1 UCB Celltech Company Information
  11.3.2 UCB Celltech Grand Mal Seizure Product Offered
  11.3.3 UCB Celltech Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 UCB Celltech Main Business Overview
  11.3.5 UCB Celltech Latest Developments
11.4 Abbott Laboratories
  11.4.1 Abbott Laboratories Company Information
  11.4.2 Abbott Laboratories Grand Mal Seizure Product Offered
  11.4.3 Abbott Laboratories Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Abbott Laboratories Main Business Overview
  11.4.5 Abbott Laboratories Latest Developments
11.5 GlaxoSmithKline
  11.5.1 GlaxoSmithKline Company Information
  11.5.2 GlaxoSmithKline Grand Mal Seizure Product Offered
  11.5.3 GlaxoSmithKline Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 GlaxoSmithKline Main Business Overview
  11.5.5 GlaxoSmithKline Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis Grand Mal Seizure Product Offered
  11.6.3 Novartis Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 Sanofi
  11.7.1 Sanofi Company Information
  11.7.2 Sanofi Grand Mal Seizure Product Offered
  11.7.3 Sanofi Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Sanofi Main Business Overview
  11.7.5 Sanofi Latest Developments
11.8 Takeda
  11.8.1 Takeda Company Information
  11.8.2 Takeda Grand Mal Seizure Product Offered
  11.8.3 Takeda Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Takeda Main Business Overview
  11.8.5 Takeda Latest Developments
11.9 Teva Pharmaceutical
  11.9.1 Teva Pharmaceutical Company Information
  11.9.2 Teva Pharmaceutical Grand Mal Seizure Product Offered
  11.9.3 Teva Pharmaceutical Grand Mal Seizure Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Teva Pharmaceutical Main Business Overview
  11.9.5 Teva Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Grand Mal Seizure Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Barbiturates
Table 3. Major Players of Hydantoin
Table 4. Major Players of Phenyltriazine
Table 5. Major Players of Iminostilbenes
Table 6. Major Players of Benzodiazepines
Table 7. Major Players of Aliphatic Carboxylic Acid
Table 8. Major Players of Others
Table 9. Grand Mal Seizure Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Grand Mal Seizure Market Size by Type (2019-2024) & ($ Millions)
Table 11. Global Grand Mal Seizure Market Size Market Share by Type (2019-2024)
Table 12. Grand Mal Seizure Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 13. Global Grand Mal Seizure Market Size by Application (2019-2024) & ($ Millions)
Table 14. Global Grand Mal Seizure Market Size Market Share by Application (2019-2024)
Table 15. Global Grand Mal Seizure Revenue by Players (2019-2024) & ($ Millions)
Table 16. Global Grand Mal Seizure Revenue Market Share by Player (2019-2024)
Table 17. Grand Mal Seizure Key Players Head office and Products Offered
Table 18. Grand Mal Seizure Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Grand Mal Seizure Market Size by Regions 2019-2024 & ($ Millions)
Table 22. Global Grand Mal Seizure Market Size Market Share by Regions (2019-2024)
Table 23. Global Grand Mal Seizure Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Grand Mal Seizure Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Grand Mal Seizure Market Size by Country (2019-2024) & ($ Millions)
Table 26. Americas Grand Mal Seizure Market Size Market Share by Country (2019-2024)
Table 27. Americas Grand Mal Seizure Market Size by Type (2019-2024) & ($ Millions)
Table 28. Americas Grand Mal Seizure Market Size Market Share by Type (2019-2024)
Table 29. Americas Grand Mal Seizure Market Size by Application (2019-2024) & ($ Millions)
Table 30. Americas Grand Mal Seizure Market Size Market Share by Application (2019-2024)
Table 31. APAC Grand Mal Seizure Market Size by Region (2019-2024) & ($ Millions)
Table 32. APAC Grand Mal Seizure Market Size Market Share by Region (2019-2024)
Table 33. APAC Grand Mal Seizure Market Size by Type (2019-2024) & ($ Millions)
Table 34. APAC Grand Mal Seizure Market Size Market Share by Type (2019-2024)
Table 35. APAC Grand Mal Seizure Market Size by Application (2019-2024) & ($ Millions)
Table 36. APAC Grand Mal Seizure Market Size Market Share by Application (2019-2024)
Table 37. Europe Grand Mal Seizure Market Size by Country (2019-2024) & ($ Millions)
Table 38. Europe Grand Mal Seizure Market Size Market Share by Country (2019-2024)
Table 39. Europe Grand Mal Seizure Market Size by Type (2019-2024) & ($ Millions)
Table 40. Europe Grand Mal Seizure Market Size Market Share by Type (2019-2024)
Table 41. Europe Grand Mal Seizure Market Size by Application (2019-2024) & ($ Millions)
Table 42. Europe Grand Mal Seizure Market Size Market Share by Application (2019-2024)
Table 43. Middle East & Africa Grand Mal Seizure Market Size by Region (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Grand Mal Seizure Market Size Market Share by Region (2019-2024)
Table 45. Middle East & Africa Grand Mal Seizure Market Size by Type (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Grand Mal Seizure Market Size Market Share by Type (2019-2024)
Table 47. Middle East & Africa Grand Mal Seizure Market Size by Application (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Grand Mal Seizure Market Size Market Share by Application (2019-2024)
Table 49. Key Market Drivers & Growth Opportunities of Grand Mal Seizure
Table 50. Key Market Challenges & Risks of Grand Mal Seizure
Table 51. Key Industry Trends of Grand Mal Seizure
Table 52. Global Grand Mal Seizure Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 53. Global Grand Mal Seizure Market Size Market Share Forecast by Regions (2025-2030)
Table 54. Global Grand Mal Seizure Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 55. Global Grand Mal Seizure Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 56. Pfizer Details, Company Type, Grand Mal Seizure Area Served and Its Competitors
Table 57. Pfizer Grand Mal Seizure Product Offered
Table 58. Pfizer Grand Mal Seizure Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Pfizer Main Business
Table 60. Pfizer Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Grand Mal Seizure Area Served and Its Competitors
Table 62. Johnson & Johnson Grand Mal Seizure Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Grand Mal Seizure Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Latest Developments
Table 66. UCB Celltech Details, Company Type, Grand Mal Seizure Area Served and Its Competitors
Table 67. UCB Celltech Grand Mal Seizure Product Offered
Table 68. UCB Celltech Main Business
Table 69. UCB Celltech Grand Mal Seizure Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. UCB Celltech Latest Developments
Table 71. Abbott Laboratories Details, Company Type, Grand Mal Seizure Area Served and Its Competitors
Table 72. Abbott Laboratories Grand Mal Seizure Product Offered
Table 73. Abbott Laboratories Main Business
Table 74. Abbott Laboratories Grand Mal Seizure Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Abbott Laboratories Latest Developments
Table 76. GlaxoSmithKline Details, Company Type, Grand Mal Seizure Area Served and Its Competitors
Table 77. GlaxoSmithKline Grand Mal Seizure Product Offered
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Grand Mal Seizure Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. GlaxoSmithKline Latest Developments
Table 81. Novartis Details, Company Type, Grand Mal Seizure Area Served and Its Competitors
Table 82. Novartis Grand Mal Seizure Product Offered
Table 83. Novartis Main Business
Table 84. Novartis Grand Mal Seizure Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Novartis Latest Developments
Table 86. Sanofi Details, Company Type, Grand Mal Seizure Area Served and Its Competitors
Table 87. Sanofi Grand Mal Seizure Product Offered
Table 88. Sanofi Main Business
Table 89. Sanofi Grand Mal Seizure Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Sanofi Latest Developments
Table 91. Takeda Details, Company Type, Grand Mal Seizure Area Served and Its Competitors
Table 92. Takeda Grand Mal Seizure Product Offered
Table 93. Takeda Main Business
Table 94. Takeda Grand Mal Seizure Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Takeda Latest Developments
Table 96. Teva Pharmaceutical Details, Company Type, Grand Mal Seizure Area Served and Its Competitors
Table 97. Teva Pharmaceutical Grand Mal Seizure Product Offered
Table 98. Teva Pharmaceutical Main Business
Table 99. Teva Pharmaceutical Grand Mal Seizure Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Teva Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Grand Mal Seizure Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Grand Mal Seizure Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Grand Mal Seizure Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Grand Mal Seizure Sales Market Share by Country/Region (2023)
Figure 8. Grand Mal Seizure Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Grand Mal Seizure Market Size Market Share by Type in 2023
Figure 10. Grand Mal Seizure in Hospitals
Figure 11. Global Grand Mal Seizure Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Grand Mal Seizure in Clinics
Figure 13. Global Grand Mal Seizure Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Grand Mal Seizure in Academic and Research Centers
Figure 15. Global Grand Mal Seizure Market: Academic and Research Centers (2019-2024) & ($ Millions)
Figure 16. Grand Mal Seizure in Others
Figure 17. Global Grand Mal Seizure Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Grand Mal Seizure Market Size Market Share by Application in 2023
Figure 19. Global Grand Mal Seizure Revenue Market Share by Player in 2023
Figure 20. Global Grand Mal Seizure Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Grand Mal Seizure Market Size 2019-2024 ($ Millions)
Figure 22. APAC Grand Mal Seizure Market Size 2019-2024 ($ Millions)
Figure 23. Europe Grand Mal Seizure Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Grand Mal Seizure Market Size 2019-2024 ($ Millions)
Figure 25. Americas Grand Mal Seizure Value Market Share by Country in 2023
Figure 26. United States Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Grand Mal Seizure Market Size Market Share by Region in 2023
Figure 31. APAC Grand Mal Seizure Market Size Market Share by Type in 2023
Figure 32. APAC Grand Mal Seizure Market Size Market Share by Application in 2023
Figure 33. China Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Grand Mal Seizure Market Size Market Share by Country in 2023
Figure 40. Europe Grand Mal Seizure Market Size Market Share by Type (2019-2024)
Figure 41. Europe Grand Mal Seizure Market Size Market Share by Application (2019-2024)
Figure 42. Germany Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Grand Mal Seizure Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Grand Mal Seizure Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Grand Mal Seizure Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Grand Mal Seizure Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 56. APAC Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 57. Europe Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 59. United States Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 60. Canada Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 63. China Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 64. Japan Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 65. Korea Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 67. India Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 68. Australia Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 69. Germany Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 70. France Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 71. UK Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 72. Italy Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 73. Russia Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 74. Spain Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 77. Israel Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Grand Mal Seizure Market Size 2025-2030 ($ Millions)
Figure 80. Global Grand Mal Seizure Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Grand Mal Seizure Market Size Market Share Forecast by Application (2025-2030)


More Publications